APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
Open Access
- 24 May 2017
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Abstract
Reduced susceptibility to infectious disease can increase the frequency of otherwise deleterious alleles. In populations of African ancestry, two apolipoprotein-L1 (APOL1) variants with a recessive kidney disease risk, named G1 and G2, occur at high frequency. APOL1 is a trypanolytic protein that confers innate resistance to most African trypanosomes, but not Trypanosoma brucei rhodesiense or T.b. gambiense, which cause human African trypanosomiasis. In this case-control study, we test the prevailing hypothesis that these APOL1 variants reduce trypanosomiasis susceptibility, resulting in their positive selection in sub-Saharan Africa. We demonstrate a five-fold dominant protective association for G2 against T.b. rhodesiense infection. Furthermore, we report unpredicted strong opposing associations with T.b. gambiense disease outcome. G2 associates with faster progression of T.b. gambiense trypanosomiasis, while G1 associates with asymptomatic carriage and undetectable parasitemia. These results implicate both forms of human African trypanosomiasis in the selection and persistence of otherwise detrimental APOL1 kidney disease variants.Keywords
Funding Information
- Wellcome (095201/Z/10/Z)
- Ministère des Affaires Etrangères
- World Health Organization
- Wellcome (099310)
This publication has 65 references indexed in Scilit:
- Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)The Lancet Neurology, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Human host determinants influencing the outcome of Trypanosoma brucei gambiense infectionsParasite Immunology, 2011
- Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesisNature Communications, 2010
- Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factorProceedings of the National Academy of Sciences, 2010
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- The Genetic Structure and History of Africans and African AmericansScience, 2009
- Sleeping sickness in Uganda: a thin line between two fatal diseasesBMJ, 2005